After exposure, the APDTRP epitope [140] with abnormally glycosylated MUC1 is identified via several antibodies against MUC1, thus activating cytotoxic T-lymphocytes (CTLs) specific to tumor antigens. The gene discussed is MUC1; the disease is neoplasm.